Showing results (31-40 of 263) with videos related to
Sort By:
Pageof 27
Molecular Metabolism|March 8, 2021
Osteocalcin and vascular function: is there a cross-talk?Alexander Tacey, Alan Hayes, Anthony Zulli, et al.Heliyon|January 22, 2025
Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigmRanmali Ranasinghe, Michael Mathai, Mohammed Abdullah Alshawsh, et al.Clinical and Experimental Pharmacology & Physiology|April 10, 2015
Role of Peptide YY in blood vessel function and atherosclerosis in a rabbit modelRenee M Smith, Rudi Klein, Peter Kruzliak, et al.Clinical and Experimental Pharmacology & Physiology|May 23, 2015
Role of Nox inhibitors plumbagin, ML090 and gp91ds-tat peptide on homocysteine thiolactone induced blood vessel dysfunctionRenee M Smith, Peter Kruzliak, Zuzana Adamcikova, et al.Nutrients|July 29, 2023
Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular DysfunctionLaura Kate Gadanec, Ulf Andersson, Vasso Apostolopoulos, et al.Current Cardiology Reviews|June 10, 2016
Towards Optimal Heart Failure Care: Couples-Oriented Strategies to Improve Patient Adherence and Health OutcomesSamia R Toukhsati, David L HareClinical Biochemistry|February 21, 2015
Predictive role of circulating endothelial-derived microparticles in cardiovascular diseasesAlexander Berezin, Anthony Zulli, Steve Kerrigan, et al.International Journal of Molecular Sciences|December 20, 2018
Melatonin May Increase Anticancer Potential of Pleiotropic DrugsBianka Bojková, Peter Kubatka, Tawar Qaradakhi, et al.Heart, Lung & Circulation|March 26, 2011
Respiratory muscle dysfunction and training in chronic heart failureEric Wong, Steve Selig, David L HareInternational Journal of Experimental Pathology|June 24, 2014
Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7)Belthrand Habiyakare, Hiba Alsaadon, Michael L Mathai, et al.Pageof 27